Insight Molecular Diagnostics Inc. Intangible Assets, Net (Excluding Goodwill)
Insight Molecular Diagnostics Inc. (IMDX) had Intangible Assets, Net (Excluding Goodwill) of $0 as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2026-03-26
- 2025-12-31: Intangible Assets, Net (Excluding Goodwill) $0.00.
- 2025-09-30: Intangible Assets, Net (Excluding Goodwill) $14.60M.
- 2025-06-30: Intangible Assets, Net (Excluding Goodwill) $14.60M.
- 2025-03-31: Intangible Assets, Net (Excluding Goodwill) $14.60M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-26 | |
| 2025-09-30 | $14.60M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $14.60M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $14.60M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $14.61M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $56.53M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $56.55M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $56.57M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $56.59M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $56.62M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $56.64M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $56.59M 10-Q · filed 2024-05-15 | $56.66M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $61.63M 10-K · filed 2024-04-16 | |
| 2022-09-30 | $88.36M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $89.34M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $90.32M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $61.72M 10-K · filed 2023-04-12 | $91.25M 10-K · filed 2022-03-11 |
| 2021-09-30 | $92.72M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $93.71M 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $47.99M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $15.01M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $15.03M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $15.05M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $15.07M 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |